This is a routine insider filing with no trading activity or material corporate event. Monitor for future Form 4 filings if Bain exercises or sells warrants, which could signal insider sentiment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $34.00entry
- T+1 · 7mo ago −25.47%α −25.13% · $25.34
- T+5 · 6mo ago −26.12%α −28.46% · $25.12
- T+20 · 6mo ago −20.21%α −25.47% · $27.13
- T+60 · 4mo ago +39.00%α +35.93% · $47.26
Price Chart
How similar events traded
Executive Summary
Linda Catharina Bain filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing her holdings in Hemab Therapeutics Holdings, Inc. (COAG). The filing is a routine insider onboarding requirement and contains no material financial or operational information about the company.
Key Facts
- Linda Catharina Bain filed an initial statement of beneficial ownership (Form 3) on April 30, 2026.
- Bain holds three tranches of warrants to purchase common stock: 25,564 shares at $2.16 (expiring 2032-03-20), 20,328 shares at $7.07 (expiring 2033-08-13), and 19,448 shares at $6.00 (expiring 2036-01-28).
- The warrants were granted on March 21, 2022, August 14, 2023, and January 29, 2026, respectively, and are fully vested except for the most recent tranche which vests monthly through January 2029.
- A power of attorney was also filed authorizing designees to file future SEC reports on Bain's behalf.
Financial Impact
No financial impact; the filing discloses warrant holdings with no transaction or monetary value stated.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-198205 |
| Document: 0001193125-26-198205-index-headers.html | 0001193125-26-198205 |
| Document: 0001193125-26-198205-index.html | 0001193125-26-198205 |
| Document: 0001193125-26-198205.txt | 0001193125-26-198205 |
Track record
19 reports on COAG
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $38.77 Now $39.06 +0.75% settles Nov 17
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $42.81 to $39.06 Now $39.06 −8.76% ▼ −8.77% −7.08% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $49.02 to $40.86 Now $39.06 −20.32% ▼ −16.65% −19.24% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $45.09 to $39.33 Now $39.06 −13.37% ▼ −12.77% −11.86% vs SPY
- Sep 25, 20267w ago 3 Neutral 2/10 Entry $33.12 to $30.59 Now $39.06 +17.93% ▼ −7.64% −8.84% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $41.22 to $35.72 Now $39.06 −5.24% ▼ −13.34% −14.19% vs SPY
- Aug 11, 202613w ago 8-K Bullish 7/10 Entry $49.87 to $52.44 Now $39.06 −21.68% ▲ +5.15% +5.56% vs SPY
- Jun 17, 202621w ago Insider Buy Neutral 2/10 Entry $29.24 to $27.72 Now $39.06 +33.58% ▼ −5.20% −3.53% vs SPY
- May 21, 202625w ago Press Release Neutral 5/10 Entry $26.30 to $28.50 Now $39.06 +48.52% ▲ +8.37% +6.52% vs SPY
- May 4, 202628w ago 8-K Neutral 4/10 Entry $25.00 to $25.90 Now $39.06 +56.24% ▲ +3.60% +1.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers